【有奖翻译】焦虑:阿尔茨海默氏症的早期指标?

点击上方“转化医学网”订阅我们！

干货 | 靠谱 | 实用  

第 19 弹

Title：Anxiety: An early indicator of Alzheimer's disease？

A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of Alzheimer's disease in older adults.

Alzheimer's disease is a neurodegenerative condition that causes the decline of cognitive function and the inability to carry out daily life activities. Past studies have suggested depression and other neuropsychiatric symptoms may be predictors of AD's progression during its "preclinical" phase, during which time brain deposits of fibrillar amyloid and pathological tau accumulate in a patient's brain. This phase can occur more than a decade before a patient's onset of mildcognitive impairment. Investigators at Brigham and Women's Hospital examined the association of brain amyloid beta and longitudinal measures of depression and depressive symptoms in cognitively normal, older adults. Their findings, published today by The American Journal of Psychiatry, suggest that higher levels of amyloid beta may be associated with increasing symptoms of anxiety in these individuals. These results support the theory that neuropsychiatric symptoms could be an early indicator of AD.

"Rather than just looking at depression as a total score, we looked at specific symptoms such as anxiety. When compared to other symptoms of depression such as sadness or loss of interest, anxiety symptoms increased over time in those with higher amyloid beta levels in the brain," said first author Nancy Donovan, MD, a geriatric psychiatrist at Brigham and Women's Hospital. "This suggests that anxiety symptoms could be a manifestation of Alzheimer's disease prior to the onset of cognitive impairment. If further research substantiates anxiety as an early indicator, it would be important for not only identifying people early on with the disease, but also, treating it and potentially slowing or preventing the disease process early on." As anxiety is common in older people, rising anxiety symptoms may prove to be most useful as a risk marker in older adults with other genetic, biological or clinical indicators of high AD risk.

Researchers derived data from the Harvard Aging Brain Study, an observational study of older adult volunteers aimed at defining neurobiological and clinical changes in early Alzheimer's disease. The participants included 270 community dwelling, cognitively normal men and women, between 62 and 90 years old, with no active psychiatric disorders. Individuals also underwent baseline imaging scans commonly used in studies of Alzheimer's disease, and annual assessments with the 30-item Geriatric Depression Scale (GDS), an assessment used to detect depression in older adults.

The team calculated total GDS scores as well as scores for three clusters symptoms of depression: apathy-anhedonia, dysphoria, and anxiety. These scores were looked at over a span of five years.

From their research, the team found that higher brain amyloid beta burden was associated with increasing anxiety symptoms over time in cognitively normal older adults. The results suggest that worsening anxious-depressive symptoms may be an early predictor of elevated amyloid beta levels - and, in turn AD—and provide support for the hypothesis that emerging neuropsychiatric symptoms represent an early manifestation of preclinical Alzheimer's disease.

Donovan notes further longitudinal follow-up is needed to determine whether these escalating depressive symptomsgive rise to clinical depression and dementia stages of Alzheimer's disease over time.

参考文献：

1.Anxiety: An early indicator of Alzheimer's disease?

2.Donovan et al. "Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults" The American Journal of Psychiatry.

投稿邮箱：wangjiani@360zhyx.com

投稿规则

1.本次活动为自愿参加，关注每日文章推送即可，每周一、周三、周五发布翻译稿件，周二、周四、周六进行翻译文章刊登；每篇文章投稿时间为2天，周一的推送截止翻译日期为当周周三，以此类推，节假日顺延投稿时间

2.投稿形式：以word文字版为准，文件名为：第几弹+姓名 。以附件形式发送至投稿邮箱。

3.参与活动均可获得转化医学网小礼品（价值30元左右）1份，被录取的文章将得到100元/篇的稿酬；您可在邮件正文或附件中留下地址号码领取礼物，因为礼物的邮寄可能需要一段时间，请您耐心等待

4.投稿文件转化医学网编辑部收到后，会进行审核，我们会在1~2个工作日内给与回复

5.得到文稿被录用邮件回复的作者可添加转化医学网内容部同事微信领取相应微信红包

6.本次活动最终解释权归转化医学网所有

END

活动

推荐

转折点——生物医药招聘第一平台